Colistimethate sodium for infection
Colobreathe, Colomycin, Promixin
Begutachtet von Sid DajaniZuletzt aktualisiert von Michael Stewart, MRPharmSZuletzt aktualisiert am 19. Januar 2023
Erfüllt die Anforderungen des Patienten redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen Sie
Teilen Sie
Colistimethate sodium is an antibiotic. It is breathed into the lungs to treat chest infections in people with cystic fibrosis.
Your doctor or nurse will show you how to use it and give you the first few doses. If you are unsure about anything, ask for further advice.
In diesem Artikel:
Lesen Sie unten weiter
About colistimethate sodium
Art des Arzneimittels | Polymyxin antibiotic |
Verwendet für | Chest infections in people with cystic fibrosis Infections caused by organisms which other antibiotics are not able to treat |
Auch genannt | Colomycin®; Promixin®; Colobreathe® (It was previously called colistin sulfomethate sodium) |
Verfügbar als | Capsules and powder for inhalation, and injection |
Colistimethate sodium is an antibiotic which is used to treat infections caused by certain types of germs (bacteria). It works by killing the bacteria causing the infection. It is not absorbed by the body if it is taken by mouth, so instead it is given by injection or breathed into the lungs (inhaled). It is inhaled when it is for an infection which affects the lungs only (such as in people with cystic fibrosis). It is given by injection for infections which affect the body generally.
The rest of this leaflet deals with colistimethate sodium when it is inhaled for chest infections in people with conditions such as cystic fibrosis.
In people with cystic fibrosis, the cells that line the airways make phlegm (mucus) that is thicker than normal. This is not cleared from the lungs easily, and can trap bacteria and lead to infection. A germ (bacterium) called Pseudomonas aeruginosa commonly lives in the thick mucus in the airways. To keep it from flaring up into repeated infections, colistimethate sodium is inhaled into the lungs by nebuliser or inhaler device.
Before using colistimethate sodium
Some medicines are not suitable for people with certain conditions, and sometimes a medicine may only be used if extra care is taken. For these reasons, before you start using colistimethate sodium it is important that your doctor knows:
Wenn Sie schwanger sind, ein Kind erwarten oder stillen.
Wenn Sie Probleme mit der Funktionsweise Ihrer Nieren haben.
Wenn Sie an einer Muskelschwäche leiden, die Myasthenia gravis genannt wird.
Wenn Sie eine seltene vererbte Blutkrankheit namens Porphyrie haben.
Wenn Sie andere Arzneimittel einnehmen. Dazu gehören alle Arzneimittel, die Sie einnehmen und die rezeptfrei erhältlich sind, sowie pflanzliche und ergänzende Arzneimittel.
Wenn Sie schon einmal eine allergische Reaktion auf ein Arzneimittel hatten.
Lesen Sie unten weiter
How to take colistimethate sodium
Before you start this treatment, read the manufacturer's printed information leaflet from inside your pack. The manufacturer's leaflet will give you more information about the medicine and a full list of the side-effects which you may experience from using it.
Use colistimethate sodium exactly as your doctor tells you to. Your doctor or nurse will give you/your child the first few doses and show you what to do. Ask for further information if there is anything you are not sure about.
If you are using a nebuliser, you will be shown how to make up the solution and how to nebulise it. As a guide only, the usual dose nebulised by adults and children over 2 years of age is 1 to 2 million units (1-2 vials) two or three times daily. This dose may be increased from time to time when needed.
If you have been given Colobreathe® capsules with an inhaler device, use one capsule in the device twice daily, 12 hours apart.
Insert the capsule widest end first into the inhaler chamber.
Pierce the capsule gradually using a two-step process (your nurse/doctor will demonstrate this for you) and remember only to pierce each capsule once.
Place the mouthpiece between your lips and form a seal around it.
Breathe in slowly but deeply so that you hear the capsule spin inside the inhaler.
Hold your breath for around ten seconds, or as long as you feel able to.
Remember to rinse out your mouth with water after each dose of Colobreathe® to remove any medicine that has deposited in your throat. This will reduce the risk of mouth infections and will help to remove the taste from the powder in the capsules.
Colobreathe® capsules must not be swallowed. They are not suitable for children under 6 years of age.
Try not to miss any doses. If you do forget a dose, have it as soon as you remember unless it is nearly time for your next dose, in which case leave out the missed dose. Do not have two doses together to make up for a forgotten dose.
Das Beste aus Ihrer Behandlung herausholen
Versuchen Sie, Ihre regelmäßigen Termine bei Ihrem Arzt einzuhalten. So kann Ihr Arzt Ihre Fortschritte überprüfen.
Your doctor may recommend another type of inhaler (a bronchodilator) to widen your airways as much as possible so that colistimethate can get deeper into your lungs. If this is the case, always use the inhaler before having a dose of colistimethate sodium.
All people with cystic fibrosis should be up to date with routine immunisations and have an annual flu jab to prevent influenza. It is also important to be immunised with pneumococcal vaccine to help prevent pneumonia caused by this bacterium.
It is important for people with cystic fibrosis to exercise and to be as active and fit as possible. So, sports and games such as running, swimming, football and tennis are encouraged.
If you are having an operation or dental treatment, tell the person carrying out the treatment that you are having this medicine. This is because colistimethate sodium can interfere with some anaesthetics and they may not be suitable for you.
Wenn Sie Medikamente kaufen, fragen Sie Ihren Apotheker, ob sie mit Ihren anderen Medikamenten eingenommen werden können.
Lesen Sie unten weiter
Can colistimethate sodium cause problems?
Along with their useful effects, most medicines can cause unwanted side-effects although not everyone experiences them. The table below contains some of the most common ones associated with inhaled colistimethate sodium. You will find a full list in the manufacturer's information leaflet supplied with your medicine. The unwanted effects often improve as your body adjusts to the new medicine, but speak with your doctor or pharmacist if any of the following continue or become troublesome.
Common colistimethate sodium side-effects - these can affect more than 1 in 10 people who use this medicine | Was kann ich tun, wenn mir das passiert? |
Coughing and chest tightness | If you have been given a medicine to widen your airways (a bronchodilator), remember to use it before you use colistimethate sodium. Let your doctor know if this problem continues |
Unpleasant taste, voice changes | After each dose, remember to rinse your mouth with water, then spit the water out |
Sore mouth and sore throat | Informieren Sie Ihren Arzt hierüber |
Krankheitsgefühl (Übelkeit) | Let your doctor know if this continues |
If you experience any other symptoms which you think may be due to this medicine, discuss them with your doctor or pharmacist.
How to store colistimethate sodium
Bewahren Sie alle Arzneimittel außerhalb der Reichweite und Sichtweite von Kindern auf.
An einem kühlen, trockenen Ort aufbewahren, vor direkter Hitze und Licht schützen.
Wichtige Informationen über alle Arzneimittel
Wichtige Informationen über alle Arzneimittel
Nehmen Sie niemals mehr als die verordnete Dosis ein. Wenn Sie den Verdacht haben, dass Sie oder jemand anderes eine Überdosis dieses Arzneimittels eingenommen haben könnte, suchen Sie die Notaufnahme Ihres örtlichen Krankenhauses auf. Nehmen Sie den Behälter mit, auch wenn er leer ist.
Dieses Arzneimittel ist für Sie bestimmt. Geben Sie es niemals anderen Menschen, auch wenn deren Zustand derselbe zu sein scheint wie Ihrer.
Bewahren Sie abgelaufene oder nicht mehr benötigte Arzneimittel nicht auf. Bringen Sie sie zu Ihrer örtlichen Apotheke, die sie für Sie entsorgt.
Wenn Sie Fragen zu diesem Arzneimittel haben, wenden Sie sich an Ihren Arzt oder Apotheker.
Nebenwirkungen eines Medikaments oder Impfstoffs melden
Wenn Sie Nebenwirkungen feststellen, können Sie diese online über die Website der Gelben Karte melden.
Weiterführende Literatur und Referenzen
- Manufacturer's PIL, Promixin® 1 million International Units (IU) Powder for Nebuliser Solution; Zambon UK Ltd (formerly Profile Pharma Limited), The electronic Medicines Compendium. Dated February 2022.
- Manufacturer's PIL, Colobreathe® inhalation powder capsules; Teva UK Limited, The electronic Medicines Compendium. Dated October 2020.
- Medicines Complete BNF 89th EditionBritish Medical Association und Royal Pharmaceutical Society of Great Britain, London.
Artikel Geschichte
Die Informationen auf dieser Seite wurden von qualifizierten Klinikern verfasst und von Fachleuten geprüft.
Nächste Überprüfung fällig: 18. Januar 2026
19 Jan 2023 | Neueste Version

Fragen, teilen, verbinden.
Stöbern Sie in Diskussionen, stellen Sie Fragen, und tauschen Sie Erfahrungen zu Hunderten von Gesundheitsthemen aus.

Fühlen Sie sich unwohl?
Beurteilen Sie Ihre Symptome online und kostenlos